Search Results - "Malik, Hassan Z."

Refine Results
  1. 1

    Inflammation and cancer: What a surgical oncologist should know by Dupré, Aurélien, Malik, Hassan Z.

    Published in European journal of surgical oncology (01-05-2018)
    “…Chronic inflammation is an aberrantly prolonged form of a protective response to a loss of tissue homeostasis and it is involved in several steps of the…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Curative-intent treatment of recurrent colorectal liver metastases: A comparison between ablation and resection by Dupré, Aurélien, Jones, Robert P., Diaz-Nieto, Rafael, Fenwick, Stephen W., Poston, Graeme J., Malik, Hassan Z.

    Published in European journal of surgical oncology (01-10-2017)
    “…Liver-limited recurrence after resection of colorectal liver metastases is a frequent occurrence, and can in some cases be treated with curative intent…”
    Get full text
    Journal Article
  5. 5

    Defined criteria for resectability improves rates of secondary resection after systemic therapy for liver limited metastatic colorectal cancer by Jones, Robert P, Hamann, Susanne, Malik, Hassan Z, Fenwick, Stephen W, Poston, Graeme J, Folprecht, Gunnar

    Published in European journal of cancer (1990) (01-06-2014)
    “…Abstract Aims Long-term survival has been demonstrated for patients with irresectable colorectal liver metastases who are brought to resection by chemotherapy…”
    Get full text
    Journal Article
  6. 6

    Preoperative prognostic score for predicting survival after hepatic resection for colorectal liver metastases by MALIK, Hassan Z, RAJENDRA PRASAD, K, HALAZUN, Karim J, ALDOORI, Amir, AL-MUKHTAR, Ahmed, GOMEZ, Dhanwant, PETER, J, LODGE, A, TOOGOOD, Giles J

    Published in Annals of surgery (01-11-2007)
    “…Despite indications for resection of colorectal liver metastases having expanded, debate continues about identifying patients that may benefit from surgery…”
    Get full text
    Journal Article
  7. 7

    From mice to men: Murine models of colorectal cancer for use in translational research by Evans, Jonathan P, Sutton, Paul A, Winiarski, Boleslaw K, Fenwick, Stephen W, Malik, Hassan Z, Vimalachandran, Dale, Tweedle, Elizabeth M, Costello, Eithne, Palmer, Daniel H, Park, B. Kevin, Kitteringham, Neil R

    Published in Critical reviews in oncology/hematology (01-02-2016)
    “…Abstract Colorectal cancer (CRC) is the third most common carcinoma worldwide and despite advances in treatment, survival for patients with metastatic disease…”
    Get full text
    Journal Article
  8. 8

    Colorectal Liver Metastases: A Critical Review of State of the Art by Jones, Robert P, Kokudo, Norihiro, Folprecht, Gunnar, Mise, Yoshihiro, Unno, Michiaki, Malik, Hassan Z, Fenwick, Stephen W, Poston, Graeme J

    Published in Liver cancer (Basel ) (01-01-2017)
    “…Background: Over 50% of patients with colorectal cancer will develop liver metastases. Only a minority of patients present with technically resectable disease…”
    Get full text
    Journal Article
  9. 9

    Evolution of surgical microwave ablation for the treatment of colorectal cancer liver metastasis: review of the literature and a single centre experience by Stättner, Stefan, Primavesi, Florian, Yip, Vincent S., Jones, Robert P., Öfner, Dietmar, Malik, Hassan Z., Fenwick, Stephen W., Poston, Graeme J.

    Published in Surgery today (Tokyo, Japan) (01-04-2015)
    “…Surgical resection is the gold standard treatment for colorectal liver metastasis, with reported five-year survival rates of 40 %. Unfortunately, despite…”
    Get full text
    Journal Article
  10. 10

    Stage IV colorectal cancer: Outcomes following the liver-first approach by de Rosa, Antonella, Gomez, Dhanwant, Hossaini, Sina, Duke, Katie, Fenwick, Stephen W., Brooks, Adam, Poston, Graema J., Malik, Hassan Z., Cameron, Iain C.

    Published in Journal of surgical oncology (01-12-2013)
    “…Background To date, there is limited data on the liver‐first approach in the management of colorectal liver metastases (CRLM). The aim of the study was to…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study by Primrose, John N, Fox, Richard P, Palmer, Daniel H, Malik, Hassan Z, Prasad, Raj, Mirza, Darius, Anthony, Alan, Corrie, Pippa, Falk, Stephen, Finch-Jones, Meg, Wasan, Harpreet, Ross, Paul, Wall, Lucy, Wadsley, Jonathan, Evans, Jeff T R, Stocken, Deborah, Praseedom, Raaj, Ma, Yuk Ting, Davidson, Brian, Neoptolemos, John P, Iveson, Tim, Raftery, James, Zhu, Shihua, Cunningham, David, Garden, O James, Stubbs, Clive, Valle, Juan W, Bridgewater, John, Primrose, JN, Fox, RP, Morement, H, Chan, O, Rees, C, Ma, YT, Hickish, T, Falk, S, Finch-Jones, M, Pope, I, Corrie, P, Crosby, T, Sothi, S, Sharkland, K, Adamson, D, Wall, L, Evans, J, Dent, J, Hombaiah, U, Iwuji, C, Anthoney, A, Bridgewater, J, Cunningham, D, Gillmore, R, Ross, P, Slater, S, Wasan, H, Waters, J, Valle, JW, Palmer, D, Malik, H, Neoptolemos, J, Faluyi, O, Sumpter, K, Dernedde, U, Maduhusudan, S, Cogill, G, Archer, C, Iveson, T, Wadsley, J, Darby, S, Peterson, M, Mukhtar, AA, Thorpe, JG, Bateman, A, Tsang, D, Cummins, S, Nolan, L, Beaumont, E, Prasad, R, Mirza, D, Stocken, D, Praseedom, R, Davidson, B, Raftery, J, Zhu, S, Garden, J, Stubbs, C, Coxon, F

    Published in The lancet oncology (01-05-2019)
    “…Despite improvements in multidisciplinary management, patients with biliary tract cancer have a poor outcome. Only 20% of patients are eligible for surgical…”
    Get full text
    Journal Article
  14. 14

    Specific mutations in KRAS codon 12 are associated with worse overall survival in patients with advanced and recurrent colorectal cancer by Jones, Robert P, Sutton, Paul A, Evans, Jonathan P, Clifford, Rachel, McAvoy, Andrew, Lewis, James, Rousseau, Abigail, Mountford, Roger, McWhirter, Derek, Malik, Hassan Z

    Published in British journal of cancer (28-03-2017)
    “…Background: Activating mutations in KRAS have been suggested as potential predictive and prognostic biomarkers. However, the prognostic impact of specific…”
    Get full text
    Journal Article
  15. 15

    Hepatic steatosis, body mass index and long term outcome in patients undergoing hepatectomy for colorectal liver metastases by Pathak, S, Tang, J.M.F, Terlizzo, M, Poston, G.J, Malik, Hassan Z

    Published in European journal of surgical oncology (01-01-2010)
    “…Abstract Background Hepatic steatosis (HS) is as an independent risk factor for morbidity and mortality post-hepatectomy. Recent studies report significant…”
    Get full text
    Journal Article
  16. 16

    Data driven decision-making for older patients with hepatocellular carcinoma by Shapey, Iestyn M., Malik, Hassan Z., de Liguori Carino, Nicola

    Published in European journal of surgical oncology (01-03-2021)
    “…Older age is a risk factor for the development of HCC. However, the treatment options available for older patients with HCC, their safety, efficacy and…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Influence of the primary tumour location in patients undergoing surgery for colorectal liver metastases by Dupré, Aurélien, Malik, Hassan Z., Jones, Robert P., Diaz-Nieto, Rafael, Fenwick, Stephen W., Poston, Graeme J.

    Published in European journal of surgical oncology (01-01-2018)
    “…The prognosis of patients undergoing liver resection for colorectal liver metastases (CLM) seems to be altered when the primary tumour is right-sided. However,…”
    Get full text
    Journal Article
  19. 19
  20. 20